🚨Live Nation Loses Antitrust Trial – Jury Finds Monopoly 🚨
- A federal jury in New York just ruled that Live Nation and Ticketmaster operated as a monopoly, violating federal and state antitrust laws.
- The verdict (after ~4 days of deliberations in a 7-week trial brought by 34 states) found the company stifled competition — e.g., by threatening venues and using dominance to control concerts & ticketing.
- Jury also determined Ticketmaster overcharged consumers by an average of $1.72 per ticket.
- Next step: Judge Arun Subramanian will decide remedies in a separate phase — this could include major divestitures, behavioral changes, or even a breakup of Live Nation/Ticketmaster.
🚨Impact on $LYV stock: 🚨
- Short-term pressure likely from the liability finding and uncertainty over harsh remedies (breakup risk was a big overhang).
- Earlier DOJ partial settlement (March 2026: up to $280M payment, some amphitheater divestitures, fee caps) had already provided some clarity and helped shares rally YTD.
- Long-term: Strong live events demand continues, but today's loss adds fresh regulatory risk and could weigh on sentiment until remedies are finalized. Analysts had targets well above recent trading levels (~$160–167 range) assuming lighter outcomes.
English
